Figure 1. Flowchart of overall study population of empagliflozin vs. sitagliptin initiators.
ESRD: end stage renal disease; HIV: human immunodeficiency virus; DPP-4: dipeptidyl peptidase-4; PS: propensity score
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.